Companies / Estonia
Cambrex Snaps Up Estonian API Firm
January 2008 | Industry NewsUS healthcare firm Cambrex has acquired, through its Swedish subsidiary Cambrex Karlskoga, Estonian active pharmaceutical ingredient (API) producer ProSyntest, as it seeks as to strengthen its European operations.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
